Common and distinct pathways for cellular activities in FGF-2 signaling induced by IL-1β in corneal endothelial cells

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 5, 2009, Pages 2067-2076

  Lee, Jeong Goo ^a   Kay, Eunduck P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE INHIBITOR; SYNAPTOPHYSIN; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CORNEA ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RABBIT; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CULTURE TECHNIQUE; DRUG EFFECT; METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIUM, CORNEAL; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLAST GROWTH FACTOR 2; IMMUNOBLOTTING; INTERLEUKIN-1BETA; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RABBITS; SIGNAL TRANSDUCTION;

EID: 65549143164     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-3135     Document Type: Article

References (53)

1. Joyce NC, Navon SE, Roy S, Zieske JD. Expression of cell cycle-associated proteins in human and rabbit corneal endothelium in situ. Invest Ophthalmol Vis Sci. 1996;37(8):1566-1575.
2. Senoo T, Joyce NC. Cell cycle kinetics in corneal endothelium from old and young donors. Invest Ophthalmol Vis Sci. 2000; 41(3):660-667.
3. Michels RG, Kenyon KR, Maumence AE. Retrocorneal fibrous membrane. Invest Ophthalmol. 1972;11(10):822-831.
4. Waring GO III. Posterior collagenous layer of the cornea: ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol. 1982; 100(1):122-134.
5. Kay ED, Cheung C-C, Jester JV, Nimni ME, Smith RE. Type I collagen and fibronectin synthesis by retrocorneal fibrous membrane. Invest Ophthalmol Vis Sci. 1982;22(2):200-212.
6. Leung EW, Rife L, Smith RE, Kay EP. Extracellular matrix components in retrocorneal fibrous membrane in comparison to corneal endothelium and Descemet's membrane. Mol Vis. 2000;6:15-23.
7. Kay EP, Smith RE, Nimni ME. Type I collagen synthesis by corneal endothelial cells modulated by polymorphonuclear leukocytes. J Biol Chem. 1985;260(8):5139-5149.
8. Kay EP, Gu X, Ninomiya Y, Smith RE. Corneal endothelial modulation: a factor released by leukocytes induces basic fibroblast growth factor that modulates cell shape and collagen. Invest Ophthalmol Vis Sci. 1993;34(3):663-672.
9. Kay EP, Gu X, Smith RE. Corneal endothelial modulation: bFGF as direct mediator and corneal endothelium modulation factor as inducer. Invest Ophthalmol Vis Sci. 1994;35(5):2427-2435.
10. Lee HT, Lee JG, Na M, Kay EP. FGF-2 induced by interleukin-1 through the action of phosphatidylinositol 3-kinase mediates endothelial mesenchymal transformation in corneal endothelial cells. J Biol Chem. 2004;279(31):32325-32332.
11. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77(8):1627-1652.
12. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87(6):2095-2147.
13. Allan SM. The role of pro and antiinflammatory cytokines in neurodegeneration. Ann N Y Acad Sci. 2000;917:84-93.
14. Gramantieri L, Casali A, Trerè D, et al. Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin Exp Immunol. 1999;115(3): 515-520.
15. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1 and IL-1 in ischemic brain damage. J Neurosci. 2001;21(15):5528-5534.
16. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13(4-5):323-340.
17. Cubitt CL, Lausch RN, Oakes JE. Synthesis of type II interleukin-1 receptors by human corneal epithelial cells but not by keratocytes. Invest Ophthalmol Vis Sci. 2001;42(3):701-704.
18. Moore JE, McMullen TCB, Campbell IL, et al. The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy. Invest Ophthalmol Vis Sci. 2002;43(9): 2905-2915.
19. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ. Defensin expression by the cornea: multiple signaling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44(5):1859-1865.
20. Djalilan AR, Nagineni CN, Mahesh SP, Smith JA, Nussenblatt RB, Hooks JJ. Inhibition of inflammatory cytokine production in human corneal cells by dexamethasone, but not cyclosporin. Cornea. 2006;25(6):709-714.
21. Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem. 1993;268(11):8140-8145.
22. Pshenichkin SP, Szekely AM, Wise BC. Transcriptional and post transcriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J Neurochem. 1994;63(2):419-428.
23. Cronauer MV, Stadlmann S, Klocker H, et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. Am J Pathol. 1999;155(6):1977-1984.
24. Sobue T, Zhang X, Florkiewicz RZ, Hurley MM. Interleukin-1 regulates FGF-2 mRNA and localization of FGF-2 protein in human osteoblasts. Biochem Biophys Res Commun. 2001;286(1):33-40.
25. Hayashi T, Matsuoka K, Saitoh M, Takeda S, Kimura M. Influence of -tumor necrosis factor and -interleukin-1 on production of angiogenetic factors and thymidine phosphorylase activity in immortalized human decidual fibroblasts in vitro. J Obstet Gynaecol Res. 2006;32(1):15-22.
26. Jung YD, Liu W, Reinmuth N, et al. Vascular endothelial growth factor is upregulated by interleukin-1 in human vascular smooth muscle cells via the p38 mitogen-activated protein kinase pathway. Angiogenesis. 2001;4(2):155-162.
27. Liu W, Reinmuth N, Stoeltzing O, et al. Cyclooxygenase-2 is up- regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways. Cancer Res. 2003;63(13):3632-3636.
28. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001; 2(3):REVIEWS 3005.
29. Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002;16(12):1446-1465.
30. Sørensen V, Nilsen T, Wiedłocha A. Functional diversity of FGF-2 isoforms by intracellular sorting. Bioessays. 2006;28(5):504-514.
31. Garcia-Maya M, Anderson AA, Kendal CE, et al. Ligand concentration is a driver of divergent signaling and pleiotropic cellular responses to FGF. J Cell Physiol. 2006;206(2):386-393.
32. Monfils M-H, Driscoll I, Melvin NR, Kobl B. Differential expression of basic fibroblast growth factor-2 in the developing rat brain. Neuroscience. 2006;141(1):213-221.
33. Yu P-J, Ferrari G, Galloway AC, Mignatti P, Pintucci G. Basic fibroblast growth factor (FGF-2): the high molecular weight forms come of age. J Cell Biochem. 2007;100(5):1100-1108.
34. Arnaud E, Touriol C, Boutonnet C, et al. A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor. Mol Cell Biol. 1999;19(1):505-514.
35. Klint P, Claesson-Welsh L. Signal transduction by fibroblast growth factor receptors. Front Biosci. 1999;4:D165-D177.
36. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005; 16(2):139-149.
37. Frinchi M, Bonomo A, Trovato-Salinaro A, et al. Fibroblast growth factor-2 and its receptor expression in proliferating precursor cells of the subventricular zone in the adult rat brain. Neurosci Lett. 2008;447(1):20-25.
38. Lee JG, Kay EP. FGF-2-mediated signal transduction during endothelial mesenchymal transformation in corneal endothelial cells. Exp Eye Res. 2006;83(6):1309-1316.
39. Lee HT, Kay EP. Regulatory role of PI 3-kinase on expression of Cdk 4 and p27, nuclear localization of Cdk4, and phosphorylation of p27 in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2003;44(4):1521-1528.
40. Lee JG, Kay EP. Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-kinase in response to fibroblast growth factor-2 stimulation. J Biol Chem. 2007;282(9):6444-6454.
41. Lee JG, Kay EP. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells. Invest Ophthalmol Vis Sci. 2008;49(1):189-196.
42. Ko MK, Kay EP. Regulatory role of FGF-2 on type I collagen expression during endothelial mesenchymal transformation. Invest Ophthalmol Vis Sci. 2005;46(12):4495-4503.
43. Lee JG, Kay EP. Cross-talk among Rho GTPases acting downstream of PI 3-kinase induces mesenchymal transformation of corneal endothelial cells mediated by FGF-2. Invest Ophthalmol Vis Sci. 2006;47(6):2358-2368.
44. Lee JG, Kay EP. FGF-2-induced wound healing in corneal endothelial cells requires Cdc42 activation and Rho inactivation through the phosphatidylinositol 3-kinase pathway. Invest Ophthalmol Vis Sci. 2006;47(4):1376-1386.
45. Rieck PW, Cholidis S, Hartmann C. Intracellular signaling pathway of FGF-2-modulated corneal endothelial cell migration during wound healing in vitro. Exp Eye Res. 2001;73(5):639-650.
46. Kay EP, Smith RE, Nimni ME. Basement membrane collagen synthesis by rabbit corneal endothelial cells in culture: evidence for an alpha chain derived from a larger biosynthetic precursor. J Biol Chem. 1982;257(12):7116-7121.
47. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-685.
48. Gu X, Kay EP. Distribution and putative roles of fibroblast growth factor-2 isoforms in corneal endothelial modulation. Invest Ophthalmol Vis Sci. 1998;39(12):2252-2258.
49. Sharma G-D, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing. J Biol Chem. 2003;278(24):21989-21997.
50. Frey MR, Dise RS, Edelblum KL, Polk DB. p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration. EMBO J. 2006;25(24):5683-5692.
51. Shahabuddin S, Ji R, Wang P, et al. CXCR3 chemokine receptor- induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. Am J Physiol Cell Physiol. 2006;291(1):C34-C39.
52. Xu L, Pathak PS, Fukumura D. Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3 -kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clin Cancer Res. 2004;10(2): 701-707.
53. Tessner TG, Muhale F, Schloemann S, Cohn SM, Morrison A, Stenson WF. Basic fibroblast growth factor upregulates cyclooxy- genase-2 in I407 cells through p38 MAP kinase. Am J Physiol Gastrointest Liver Physiol. 2003;284(2):G269-G279.